My Quote Request
6505-01-367-5510
20 Products
AC-1016
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013675510
NSN
6505-01-367-5510
AC-1016
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013675510
NSN
6505-01-367-5510
MFG
U S DEPT OF VETERANS AFFAIRS
Description
PRIMARY CONTAINER CONTENT QUANTITY: 128.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 6 GALLONS PER PACKAGE
Related Searches:
PRELONE
PREDNISOLONE ORAL SOLUTION
NSN, MFG P/N
6505013671081
NSN
6505-01-367-1081
MFG
AERO PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLILITERS PREDNISOLONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISOLONE ORAL SOLUTION CHERRY FLAVORED 15MG/5ML 240ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CHERRY FLAVORED,W/5 PCT ALCOHOL
Related Searches:
NDC00409-1966-07
SODIUM CHLORIDE INJECTION,BACTERIOSTATIC,USP
NSN, MFG P/N
6505013674584
NSN
6505-01-367-4584
NDC00409-1966-07
SODIUM CHLORIDE INJECTION,BACTERIOSTATIC,USP
NSN, MFG P/N
6505013674584
NSN
6505-01-367-4584
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION BACTERIOSTATIC USP 30ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: PRESERVED WITH 0.9% BENZYL ALCOHOL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0924-30
SODIUM CHLORIDE INJECTION,BACTERIOSTATIC,USP
NSN, MFG P/N
6505013674584
NSN
6505-01-367-4584
NDC63323-0924-30
SODIUM CHLORIDE INJECTION,BACTERIOSTATIC,USP
NSN, MFG P/N
6505013674584
NSN
6505-01-367-4584
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION BACTERIOSTATIC USP 30ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: PRESERVED WITH 0.9% BENZYL ALCOHOL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CALPHOSAN
CALCIUM LACTATE AND
NSN, MFG P/N
6505013675224
NSN
6505-01-367-5224
MFG
GLENWOOD LLC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 50 MG CALCIUM LACTATE AND 50 MG CALCIUM GLYCERPHOSPHATE PER 10 ML; 60 ML PER MULTIDOSE VIAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM LACTATE AND CALCIUM GYLCERPHOSPHATE INJECTION 60ML VIAL
Related Searches:
F92I227
CALCIUM LACTATE AND
NSN, MFG P/N
6505013675224
NSN
6505-01-367-5224
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 50 MG CALCIUM LACTATE AND 50 MG CALCIUM GLYCERPHOSPHATE PER 10 ML; 60 ML PER MULTIDOSE VIAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM LACTATE AND CALCIUM GYLCERPHOSPHATE INJECTION 60ML VIAL
Related Searches:
NDC00516-0060-60
CALCIUM LACTATE AND
NSN, MFG P/N
6505013675224
NSN
6505-01-367-5224
MFG
GLENWOOD LLC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 50 MG CALCIUM LACTATE AND 50 MG CALCIUM GLYCERPHOSPHATE PER 10 ML; 60 ML PER MULTIDOSE VIAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM LACTATE AND CALCIUM GYLCERPHOSPHATE INJECTION 60ML VIAL
Related Searches:
NDC00069-1520-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675242
NSN
6505-01-367-5242
NDC00069-1520-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675242
NSN
6505-01-367-5242
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 2.5MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NORVASC
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675242
NSN
6505-01-367-5242
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 2.5MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00069-1540-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675243
NSN
6505-01-367-5243
NDC00069-1540-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675243
NSN
6505-01-367-5243
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 10MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
NORVASC
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675243
NSN
6505-01-367-5243
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 10MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
NDC00069-1530-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675244
NSN
6505-01-367-5244
NDC00069-1530-68
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675244
NSN
6505-01-367-5244
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 5MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59762-1530-01
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675244
NSN
6505-01-367-5244
NDC59762-1530-01
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675244
NSN
6505-01-367-5244
MFG
DIXON-SHANE LLC DBA R & S NORTHEAST
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 5MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NORVASC
AMLODIPINE BESYLATE TABLETS
NSN, MFG P/N
6505013675244
NSN
6505-01-367-5244
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS AMLODIPINE BESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMLODIPINE BESYLATE TABLETS 5MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
F92G223
INTERFERON ALFA-N3
NSN, MFG P/N
6505013675248
NSN
6505-01-367-5248
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS 5000000 INTERNATIONAL UNITS INTERFERON ALFA-N3 PER ML; INTRALESIONAL; MULTI DOSE VIAL,STERILE; NOT RECOMBINANT; 1 ML REQUIRES REFRIGERATION; 12 PER PACKAGE; ANTINEOPLASTIC DRUG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INTERFERON ALFA-N3 INJECSTION 5000000 I.U./ML 12S
Related Searches:
NDC54746-0001-01
INTERFERON ALFA-N3
NSN, MFG P/N
6505013675248
NSN
6505-01-367-5248
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS 5000000 INTERNATIONAL UNITS INTERFERON ALFA-N3 PER ML; INTRALESIONAL; MULTI DOSE VIAL,STERILE; NOT RECOMBINANT; 1 ML REQUIRES REFRIGERATION; 12 PER PACKAGE; ANTINEOPLASTIC DRUG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INTERFERON ALFA-N3 INJECSTION 5000000 I.U./ML 12S
Related Searches:
KETALAR
KETAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013675261
NSN
6505-01-367-5261
KETALAR
KETAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013675261
NSN
6505-01-367-5261
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETAMINE HYDROCHLORIDE INJECTION USP 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EQUIVALENT TO 10 MG KETAMINE PER ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC42023-0113-10
KETAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013675261
NSN
6505-01-367-5261
NDC42023-0113-10
KETAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013675261
NSN
6505-01-367-5261
MFG
MONARCH PHARMACEUTICALS INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETAMINE HYDROCHLORIDE INJECTION USP 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EQUIVALENT TO 10 MG KETAMINE PER ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
AQUASOL E
VITAMIN E ORAL SOLUTION
NSN, MFG P/N
6505013675262
NSN
6505-01-367-5262
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VITAMIN E ORAL SOLUTION 30ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
SPECIAL FEATURES: W/SCREW-CAP CLOSURE AND CALIBRATED DROPPER
Related Searches:
NDC00186-5800-30
VITAMIN E ORAL SOLUTION
NSN, MFG P/N
6505013675262
NSN
6505-01-367-5262
NDC00186-5800-30
VITAMIN E ORAL SOLUTION
NSN, MFG P/N
6505013675262
NSN
6505-01-367-5262
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VITAMIN E ORAL SOLUTION 30ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
SPECIAL FEATURES: W/SCREW-CAP CLOSURE AND CALIBRATED DROPPER